NXNN - Nexeon MedSystems Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
8.00
0.00 (0.00%)
As of 9:57AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close8.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume2,541
Market Cap15.725M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.35
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.00
Trade prices are not sourced from all markets
  • GlobeNewswire7 days ago

    Nexeon MedSystems Announces Second Quarter 2018 Financial Results

    Nexeon MedSystems Inc (”Nexeon”) (NXNN), a neurostimulation medical device company, announced today financial results for the second quarter of 2018. Nexeon completed two additional pre-submission interactions with the United States Food and Drug Administration (“FDA”) to determine the scope of requirements for approval of the Viant™ System for the Parkinson’s disease indication. Nexeon MedSystems Puerto Rico Operations Company Corporation (“NXPROC”), a wholly-owned subsidiary of Nexeon, received notification from the National Institute of Neurological Disorders and Stroke (NINDS) that it is conditionally approved for funding of an U44 Cooperative Agreement Award under the NIH BRAIN Initiative.

  • MarketWatch2 months ago

    Medical device maker Nexeon MedSystems files for IPO

    Medical device maker Nexeon MedSystems Inc. has filed for an initial public offering, and plans to list its shares on Nasdaq, according to a regulatory filing. The company's common stock currently trades ...

  • ACCESSWIRE8 months ago

    SeeThruEquity Issues Update on Nexeon MedSystems, Inc. (OTCQB: NXNN)

    NEW YORK, NY / ACCESSWIRE / December 21, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has ...

  • Nexeon MedSystems Provides Shareholder Update
    PR Newswire9 months ago

    Nexeon MedSystems Provides Shareholder Update

    Company to Host Conference Call November 20, 2017 4pm CST DALLAS , Nov. 20, 2017 /PRNewswire/ -- Nexeon MedSystems Inc. (OTCQB: NXNN, "Nexeon", "the Company"), is providing shareholders ...

  • Nexeon MedSystems Begins Trading as NXNN
    PR Newswire11 months ago

    Nexeon MedSystems Begins Trading as NXNN

    "I'm proud of our management team for implementing and delivering on innovative financing strategies in much the same fashion as our engineers do," said Nexeon CEO Will Rosellini. In June 2017, the Securities and Exchange Committee (SEC) declared effective the Company's S-1 Registration Statement. The S-1 registered 5,332,496 shares of the Company's common stock.

  • PR Newswire11 months ago

    Nexeon MedSystems "OTCQB:NXNN" Acquires Belgian Manufacturer

    LIEGE, Belgium, Sept. 6, 2017 /PRNewswire/ -- Nexeon MedSystems ("Nexeon" or "the Company") (NXNN) announced today that it has exercised its option to acquire Nexeon Medsystems Belgium, SPRL ("NMB").  This Belgian-based company has been operating since 2013 developing neurostimulation products. NMB recently acquired Medi-Line, a Belgian medical device manufacturer with financing support provided by KBC and CBC Bank.  Medi-Line has expertise in active and non-active implants, and it has been profitable for its complete 25-year corporate history. For more information about the transaction, please review the Form 8-K.